Discovery Life Sciences and Partner to Advance Liquid Biopsy Development and Immunotherapy Research

SAN DIEGO–(BUSINESS WIRE)– #fasterscience–, the healthcare industry’s leading marketplace for outsourced research, and Discovery Life Sciences™ (Discovery), a global leader in biospecimen solutions, genomic, cell and immunohistochemistry (IHC) services, have partnered to offer researchers online access to Illumina’s TruSight™ Oncology 500 (TSO500) technology. The TSO500 technology was recently added to HudsonAlpha Discovery™, Discovery’s highly regarded sequencing and bioinformatics laboratory.

Click to view original post

Advertise With Us